RDX5791, a First-in-Class Minimally Systemic NHE3 Inhibitor...

Gastroenterology 2011 Vol. 140; Iss. 5-supp-S1

RDX5791, a First-in-Class Minimally Systemic NHE3 Inhibitor in Clinical Development for CIC and IBS-C, Increases Intestinal Sodium Leading to Enhanced Intestinal Fluid Volume and Transit

Andrew G. Spencer, Jeffrey W. Jacobs, Michael R. Leadbetter, Christopher W. Carreras, Xunxiang Du, Noah Bell, Samantha Koo-McCoy, Jill N. Kohler, Eric Labonté, David P. Rosenbaum, Marc Navre, Dominiqu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
140
Year:
2011
Language:
english
DOI:
10.1016/s0016-5085(11)60405-8
File:
PDF, 90 KB
english, 2011
Conversion to is in progress
Conversion to is failed